Zomedica Corp. (ZOMDF)
0.0789
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Zomedica Profit Margin (Quarterly) : -39.58% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -39.58% |
| March 31, 2026 | -51.53% |
| December 31, 2025 | -43.26% |
| September 30, 2025 | -75.61% |
| June 30, 2025 | -106.2% |
| March 31, 2025 | -981.7% |
| December 31, 2024 | -91.12% |
| September 30, 2024 | -95.71% |
| June 30, 2024 | -390.3% |
| March 31, 2024 | -146.3% |
| December 31, 2023 | -305.4% |
| Date | Value |
|---|---|
| September 30, 2023 | -7.74% |
| June 30, 2023 | -87.19% |
| March 31, 2023 | -116.5% |
| December 31, 2022 | -45.62% |
| September 30, 2022 | -104.6% |
| June 30, 2022 | -124.2% |
| March 31, 2022 | -105.0% |
| December 31, 2021 | -80.62% |
| September 30, 2021 | -28.20K% |
| June 30, 2021 | -30.00K% |
| March 31, 2021 | -28.63K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biomerica, Inc. | -130.9% |
| Univec, Inc. | -1.48K% |
| Lantheus Holdings, Inc. | 19.33% |
| IDEXX Laboratories, Inc. | 27.82% |
| Neogen Corp. | -5.02% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.37% |
| Return on Assets | -14.94% |
| Return on Invested Capital | -16.07% |
| Gross Profit Margin (Quarterly) | 63.51% |
| Operating Margin (Quarterly) | -42.92% |
| Return on Net Operating Assets | -26.25% |